sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY February 2018 | Archived Issues

FDA Updates Warning About Antidepressant Pristiq

The U.S. Food and Drug Administration has updated a warning about the antidepressant Pristiq (desvenlafaxine succinate) that it can lead to serotonin syndrome, a potentially life-threatening condition. The risk of suicidal thoughts and behaviors in pediatric and young adult patients is increased when used with other drugs that impair metabolism of serotonin.

The FDA has more information.